AwardTape · Defense awards · Medical · Drugs and biologicals · N6264519P0058
N6264519P0058: $270K purchase order to Prolacta Bioscience, Inc
Prolacta Bioscience, Inc holds a purchase order from Defense Health Agency with $270K obligated since Oct 2023 and $3.3M obligated over its life, against a ceiling of $3.3M. Latest action Mar 27, 2024.
Prolact+6 hmf
| PIID | N6264519P0058 |
|---|---|
| Type | purchase order |
| Company | Prolacta Bioscience, Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY HCD WEST |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING |
| Obligated since Oct 2023 | $270K |
| Total obligated (lifetime) | $3.3M |
| Ceiling (base and all options) | $3.3M |
| Base date | Oct 1, 2019 |
| Latest action | Mar 27, 2024 |
| End date | Sep 30, 2024 |
| Actions since Oct 2023 | 2 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | CA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial